China National Accord Medicines Corporation Ltd. (000028.SZ), a subsidiary of SINOPHARM (01099), announced preliminary financial results for the three months ended March 31, 2026. The company reported operating revenue of 17.823 billion yuan, representing a decrease of 2.57% compared to the same period last year. Net profit attributable to shareholders of the listed company was 287 million yuan, down 12.36% year-on-year. Basic earnings per share stood at 0.52 yuan.